Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2913-2920

  Chen, Zongyu ^a   Rowland, Raymond R R ^a,b   Anderson, Grant W ^a   Palmer, Gene A ^a,c   Plagemann, Peter G W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR HORN CELL; ARTICLE; CONTROLLED STUDY; LACTIC DEHYDROGENASE TOGAVIRUS; MOUSE; NEUROPATHOLOGY; NONHUMAN; OPEN READING FRAME; POLIOMYELITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS NEUTRALIZATION;

EID: 0030936128     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2913-2920.1997     Document Type: Article

References (34)

1. Anderson, G. W., C. Even, R. R. R. Rowland, G. A. Palmer, J. T. Harty, and P. G. W. Plagemann. 1995. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J. Neurovirol. 1:244-252.
2. Anderson, G. W., G. A. Palmer, R. R. R. Rowland, C. Even, and P. G. W. Plagemann. 1995. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J. Virol. 69:308-319.
3. Anderson, G. W., G. A. Palmer, R. R. R. Rowland, C. Even, and P. G. W. Plagemann. 1995. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons. J. Gen. Virol. 76:581-592.
4. Anderson, G. W., R. R. R. Rowland, G. A. Palmer, C. Even, and P. G. W. Plagemann. 1995. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers concomitant with polyclonal activation of B cells. J. Virol. 69:5177-5185.
5. Brinton-Darnell, M., and P. G. W. Plagemann. 1975. Structural and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J. Virol. 16:420-433.
6. Cafruny, W. A., S. P. K. Chan, J. T. Harty, S. Yousefi, K. Kowalchyk, D. McDonald, B. Foreman, G. Budweg, and P. G. W. Plagemann. 1986. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res. 5:357-375.
7. Cafruny, W. A., C. R. Strancke, K. Kowalchyk, and P. G. W. Plagemann. 1986. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantitation of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease. J. Gen. Virol. 67:27-37.
8. Cavanagh, D., D. A. Brien, M. Brinton, L. Enjuanes, K. V. Holmes, M. C. Horzinek, M. M. C. Lai, H. Laude, P. G. W. Plagemann, S. Siddell, W. J. M. Spaan, F. Taguchi, and P. J. Talbot. 1994. Revision of the taxonomy of the Coronavirus, Torovirus and Arterivirus genera. Arch. Virol. 135:227-237.
9. Chen, Z., L. Kuo, R. R. R. Rowland, C. Even, K. A. Faaberg, and P. G. W. Plagemann. 1993. Sequence of 3′-end of genome and of 5′-end of open reading frame 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5′-leader and bodies of seven subgenomic mRNAs. J. Gen. Virol. 74:643-660.
10. Dockter, J., C. F. Evans, A. Tishon, and M. B. A. Oldstone. 1996. Competitive selection in vivo by a cell for one variant over another: implications for RNA quasispecies in vivo. J. Virol. 70:1799-1803.
11. Domingo, F., and Holland, J. J. 1994. Mutation rates and rapid evolution of RNA viruses, p. 161-184. In S. S. Morse (ed.), The evolutionary biology of viruses. Raven Press, New York, N.Y.
12. Even, C., R. R. R. Rowland, and P. G. W. Plagemann. 1995. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus hut disappear during chronic phase of infection. J. Virol. 69: 5666-5676.
13. Faaberg, K. S., and P. G. W. Plagemann. 1995. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology 212:512-525.
14. Faaberg, K. S., C. Even, G. A. Palmer, and P. G. W. Plagemann. 1995. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J. Virol. 69:613-617.
15. Faaberg, K. S., G. A. Palmer, C. Even, G. W. Anderson, and P. G. W. Plagemann. 1995. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity. Virus Res. 39:331-340.
16. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
17. Godeny, E. K., L. Chen, S. N. Kumar, S. L. Methven, E. V. Koonin, and M. A. Brinton. 1993. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology 194:585-596.
18. Harty, J. T., and P. G. W. Plagemann. 1990. Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus. J. Virol. 64:6257-6262.
19. Holland, J. J., J. C. de la Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-18.
20. Kowalchyk, K., and P. G. W. Plagemann. 1985. Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulation of macrophages. Virus Res. 2:211-229.
21. Lawrence, C. B., and D. A. Goldman. 1988. Definition and identification of homology domains. CABIOS 4:25-33.
22. Martinez, D., M. D. Brinton, T. G. Tachovsky, and A. H. Phelps. 1980. Identification of lactate dehydrogenase-elevating virus as etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice. Infect. Immun. 27:979-987.
23. Murphy, W. H., J. J. Mazur, and S. A. Fulton. 1987. Animal model for motor neuron disease, p. 135-155. In W. M. H. Behan, P. O. Behan, and J. A. Aarli (ed.), Clinical neuroimmunology. Blackwell Scientific Publications, Oxford, England.
24. Murphy, W. H., J. F. Nawrocki, and L. R. Pease. 1983. Age-dependent paralytic viral infection in C58 mice: possible implication in human neurologic disease. Prog. Brain Res. 59:291-303.
25. Nawrocki, J. F., L. R. Pease, and W. H. Murphy. 1980. Etiologic role of lactate dehydrogenase-elevating virus infection in an age-dependent neuropathic disease in C58 mice. Virology 103:259-264.
26. Palmer, G. A., L. Kuo, Z. Chen, K. S. Faaberg, and P. G. W. Plagemann. 1995. Sequence of genome of lactate dehydrogenase-elevating virus. Heterogeneity between strains P and C. Virology 209:637-642.
27. Palmer, G. A., Z. Chen, R. R. R. Rowland, G. W. Anderson, and P. G. W. Plagemann. Non-neuropathogenic lactate dehydrogenase-elevating virus (LDV) infects cells in the leptomeninges only poorly and infection of these cells by neuropathogenic LDV is inhibited by antiviral antibodies. Submitted for publication.
28. Plagemann, P. G. W. 1996. Lactate dehydrogenase-elevating virus and related viruses, p. 1105-1120. In B. N. Fields, D. M. Knipe and P. M. Howley (ed.), Virology. Raven Press, New York, N.Y.
29. Plagemann, P. G. W., K. F. Gregory, H. E. Swim, and K. K. W. Chan. 1963. Plasma lactic dehydrogenase elevating agent of mice: distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can. J. Microbiol. 9:75-86.
30. Plagemann, P. G. W., and V. Moennig. 1992. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv. Virus Res. 41:99-192.
31. Plagemann, P. G. W., R. R. R. Rowland, C. Even, and K. S. Faaberg. 1995. Lactate dehydrogenase-elevating virus - an ideal persistent virus? Semin. Immunopathol. 17:167-186.
32. Rowson, K. F. K., and B. W. J. Mahy. 1975. Lactic dehydrogenase virus. Virol. Monogr. 13:1-121.
33. Stroop, W. G., and M. Brinton. 1983. Mouse strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection. Lab. Invest. 49:334-344.
34. Villarete, L., T. Somasundaram, and R. Ahmed. 1994. Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. J. Virol. 68:7490-7496.